The Chilean infant Nutrition Trial was a prospective, randomized, double-blind, controlled study conducted in Santiago, Chile, between 2016 and The study aimed to evaluate growth and body composition changes between birth and two years of age in a large sample of children who were randomized to receive either infant formula with or without added MFGM (milk fat globule membrane) through 12 months of age or received human milk as part of the reference group. In a subsample of 160 children, neurodevelopmental were assessed at 6 months and 24 months.
Age range
10 Years – 12 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
To determine if intake of bMFGM during the first year improves brain structure at 9 ys.
Timeframe: MRI assessment will be performed at 9 years old in a session of 45 minutes
To determine if intake of bMFGM during the first year improves EF measures by ERPs at 9ys.
Timeframe: ERPs assessment will be performed at 9 years old in a a second session of 90 minutes .
To determine if intake of bMFGM during the first year improves EF measures by questionnaire EFECO.
Timeframe: EFECO will be answered by the adult that ERPs assessment will be performed at 9 years old in a a second session of 90 minutes .